Personalized treatments in neuropsychiatric disorders-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Personalized treatments in neuropsychiatric disorders

Published:2021-07 Issue:5 Volume:82 Page:618-620
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev Res

Author:

Squassina Alessio¹²^ORCID

Affiliation:

1. Section of Neuroscience and Clinical Pharmacology, Department of Biomedical Sciences, Faculty of Medicine and Surgery University of Cagliari Cagliari Italy

2. Department of Psychiatry, Faculty of Medicine Dalhousie University Halifax Nova Scotia Canada

Publisher

Wiley

Subject

Drug Discovery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ddr.21854

Reference15 articles.

1. Influence of dopamine, noradrenaline, and serotonin transporters on the pharmacogenetics of Atremorine in Parkinson's disease;Cacabelos R.;Drug Development Research,2021

2. Anatomical distribution and expression of CYP in humans: Neuropharmacological implications;Fanni D.;Drug Development Research,2021

3. The global burden of neurological disorders: translating evidence into policy

4. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

5. Tardive dyskinesia among patients using antipsychotic medications in customary clinical care in the United States

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP